Quality-of-life utilities
. | . | Range . | . | |
|---|---|---|---|---|
. | Utility . | Low . | High . | |
| Alive with MDS | 0.95 | 0.85 | 0.99 | |
| Alive after transplantation | 0.92 | 0.80 | 0.95 | |
| Alive with AML | 0.85 | 0.70 | 0.90 | |
| Alive with relapsed MDS/AML | 0.57 | 0.50 | 0.70 | |
. | . | Range . | . | |
|---|---|---|---|---|
. | Utility . | Low . | High . | |
| Alive with MDS | 0.95 | 0.85 | 0.99 | |
| Alive after transplantation | 0.92 | 0.80 | 0.95 | |
| Alive with AML | 0.85 | 0.70 | 0.90 | |
| Alive with relapsed MDS/AML | 0.57 | 0.50 | 0.70 | |
Utilities are numerical representations of the perceived value of a given health state and are expressed as values between 0 and 1. Utilities were incorporated into quality-adjusted calculations and were tested across the ranges shown in sensitivity analyses. MDS indicates myelodysplastic syndrome; AML, acute myelogenous leukemia.